We purified the major mitogen for human smooth musclelike cells in leiomyoma extracts by sequential liquid chromatography on (a) carboxymethyl-Sepharose, (b) heparinSepharose columns, (c) cartridges of C18 silica, and (d) linear gradient reverse-phase high performance liquid chromatography. The mitogenic activity of the leiomyoma extract throughout purification was tested by tritiated thymidine incorporation and DNA content in NIH/3T3 fibroblasts and KW human smooth muscle-like cells. Purification of the leiomyoma-derived growth factor (LDGF) for KW smooth muscle-like cells confirmed that its partial NH2-terminal amino acid (aa) sequence (1-20 aa) was identical to 113-132 aa of the human cysteine-rich protein (hCRP). A synthetic peptide which was engineered based on the purified aa sequence, stimulated the proliferation and growth of KW cells. An oligonucleotide probe constructed by the cDNA of the hcrp gene that encodes this aa sequence depicted the expression of 1.9-kb LDGF mRNA in leiomyomas and myometrium. The expression of the LDGF mRNA was three to sixfold higher in leiomyomas compared with adjacent myometrium of women harboring leiomyomas by in situ hybridization analysis. These data suggest that LDGF may participate in the pathophysiology of uterine leiomyomas. (J. Clin. Invest. 1995.96:751-758.)
Introduction
Recently, several biologically active peptides, including (a) metastasis-stimulating factor(s) from mouse uterus (1, 2) ; (b) rat, rabbit, and bovine uterus-derived growth factors (3); (c) 17-kD heparnn-binding growth factor (HBGF-8) partially purified from bovine uterus similar to basic fibroblast growth factor (bFGF) (4); (d) mitogens(s) distinct from EGF in porcine uterus extracts (5, 6) ; and (e) human uterine muscle-derived plicated in uterine physiology and pathophysiology (7) (8) (9) (10) (11) . Growth factors, such as IGFs, EGF, PDGF, TGF/3s, bFGF, and their receptors, were postulated to play an important role in human uterine physiopathology (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) , including leiomyomas (15, 16, 19, [24] [25] [26] [27] .
Our previous studies documented that uterine tissues contain mitogens and inhibitors for skin fibroblasts, osteoblasts, myoblasts, and rat aorta smooth muscle-like cells (7) (8) (9) . Moreover, preferential mitogens for rat and mouse muscle-like cells were extracted from leiomyomas that were undetectable in myometrial and endometrial extracts (10, 11) .
Herein we report the final purification and the partial amino acid (aa) sequence of an LDGF with preferential activity in KW human uterine smooth muscle-like cells. This material contained activity equivalent to IGF-I, and its NH2-terminal sequence (1-20 aa) encompassed part (113-132 aa) of the LIM motif (zinc finger) of human cysteine-rich protein (hCRP). Using a synthetic peptide comprising this amino acid sequence and an oligonucleotide probe synthetically engineered by the cDNA sequence that encodes this aa sequence, we confirmed that (a) synthetic peptide is mitogenic for uterine smooth muscle cells, and (b) there exists the expression of a discrete signal at 1.9-kb LDGF mRNA in uterine tissues. The expression of the LDGF mRNA was remarkably higher (three-to sixfold) in leiomyomas than in the adjacent myometrium of women harboring leiomyomas as detected by in situ hybridization analysis. These data suggest that this LDGF is possibly linked with the pathophysiology of uterine leiomyomas.
Methods
Source, handling oftissues, and extraction method. Uterine tissues were obtained at hysterectomy of premenopausal women harboring leiomyomas; these women had received no therapy before surgery. Leiomyoma tissues were carefully washed with ice-cold and serum-free HBSS and either extracted or stored at -80°C without preservatives until use. Tissues were minced and extracted in 40 ml/gram of 50 mM of ammonium acetate, pH 5.5, containing 50 mg/liter PMSF, 10 mg/liter soybean trypsin inhibitor, and 1 mg/liter aprotinin for 2 h at 4°C with agitation ( 10, 11) . The extract was centrifuged at 10,000 g for 30 min and filtered with 0.45-MM filters. The extract was dried and redissolved in DME/ F-12, and aliquots were tested for bioactivity and protein content (7, 10, 11). This study was approved by the local ethics committe (Laval University, Ste. foy, Canada) according to the guidelines of Medical Research Council (MRC) of Canada for the use of human tissues in medical research.
Bioassay systems-mitogenic activity. The mouse NIH/3T3 fibroblasts were from the American Type Culture Collection (RL1658; ATCC, Bethesda MD), and the KW human uterine smooth musclelike cells were spontaneously propagated in a cell line after continuous subcultures of fast-growing cells isolated by enzymatic digestion from normal human uterine muscle (28) . In our laboratory, the KW cell line was characterized to express phenotype compatible with human smooth muscle cells, including the expression of smooth muscle cell-specific alpha actin (29) .
These cells were used as indicator bioassay systems to assess the mitogenic activity of leiomyoma fractions throughout purification. Cell lines were maintained in DME/F-12 containing 10% calf serum in 75-cm tissue culture flasks. When the cultures reached confluence, the cells were trypsinized using a mixture of 0.1% trypsin (Sigma Chemical Co.; St. Louis, MO) and 0.01% EDTA (Sigma Chemical Co.) in HBBS and precipitated by low-speed centrifugation. Then the cells were counted in a hemocytometer using trypan blue exclusion to assess viability and plated at 5 x 104 cells/well in 24-well plates using DME/F-12 medium containing 10% calf serum. After 24 h, the cells were changed to serum-free medium for an additional 24 h and then stimulated with aliquots of the fractions under investigation (7) (8) (9) (10) (11) 29) .
The rate of the tritiated thymidine incorporation was assessed by adding 2 yCi of tritiated thymidine (sp act; 20 Ci-mmol; ICN Radiochemicals, Boston, MA) to each well. The medium was aspirated and the cells washed twice with ice-cold PBS. Then 1 ml of ice-cold trichloroacetic acid (10% TCA) was added. The TCA-insoluble material was dissolved in 0.5 ml of 0.6 N NaOH, and radioactivity (cpm/pg DNA) was measured by liquid scintillation spectrometry (7) (8) (9) (10) (11) . The DNA content was also evaluated (,tg DNA/well) in monolayer cultures as previously described (7) (8) (9) (10) (11) 29) . Mitogenic activity throughout purification was analyzed as units per microgram of protein; 1 U was defined as the stimulation in tritiated thymidine incorporation and DNA content (percent above control) achieved by 10 ng/ml of IGF-I in the KW smooth muscle-like cells and NIH/3T3 fibroblasts. The cell number was counted by a hemocytometer using the trypan blue exclusion method in cell cultures treated with mitogens for 4 consecutive days (7) (8) (9) (10) (11) 29 Carboxymethyl (CM)-Sepharose chromatography (CM-c). CM-c was performed on a 12 x 5.8 cm column preequilibrated with 50 mM ammonium acetate, pH 5.5, at 4°C. The flow rate was 200 ml/h. Leiomyoma extracts were first loaded on the column and then washed by 50 mM ammonium acetate, pH 5.5. CM-c was eluted by 1.2 M NaCl (onestep elution) as previously described (11) .
Heparin-Sepharose chromatography (HS-c). HS-c was performed on a 1.6 X 18 cm column preequilibrated with 20 mM Tris-HCl containing 0.6 M NaCl, pH 7.1, at 4°C. The flow rate was 50 ml/h. The protein fractions eluted from CM-c were diluted using Tris 20 mM, pH 7.1, to 0.6 M NaCl and adjusted to pH 7.1 using 1 M Tris-HCl. These fractions were then loaded onto HS-c and eluted by 2.0 M NaCl (onestep elution). Eluates were analyzed by SDS-PAGE as previously described (30 (33) . The PTH-amino acid yield for each cycle was normalized according to a PTH-Norleucine standard added directly before separation; the initial and repetitive yields were obtained by linear regression from the yields of selected stable PTH derivatives (33) . The synthetic peptides were engineered by the solid phase method at Sheldon Biotechnology Center, McGill University, Montreal, Canada. These synthetic peptides were purified by rHPLC and characterized by amino acid analysis and mass spectra analysis.
Extraction of total RNA and Northern analysis. Leiomyomal and myometrial total RNA was extracted from tissues obtained at surgery from premenopausal women harboring leiomyomas; these women had received no therapy before hysterectomy. From each hysterectomy, we extracted leiomyomal and myometrial total RNA using an acid guanidinium thiocyanate, phenol, and chlorophorm extraction procedure (34) . The samples of total RNA (10 jig) were electrophoresed through formaldehyde-agarose slab gels, transferred to GeneScreen Plus, and hybridized overnight with 106 cpm/ml probe at 42°C in a buffer containing 5 x SSPE (750 mM NaCl, 50 mM NaH2PO4, pH 7.6,5 mM Na2 EDTA), 50% formamide, 5 x Denhardt's, and 2% SDS. Membranes were washed in 2 x SSPE, 2% SDS at 65°C for 30 min. Membranes were autoradiographed at -70°C with Fisher Biotech intensifying screens (Fisher, Pittsburgh, PA) for various times, depending on the signal intensities. Quantification of the band intensities was carried out using a Phosphorlmager, and data were analyzed using ImageQuant Software v3.0 (Molecular Dynamics, Inc., Sunnyvale, CA). The probes were stripped from the membranes by heating to 95°C in 10 mM Tris, pH 7.5, 1% SDS for 20-30 min before rehybridization with another probe. The oligonucleotide probe (5 '-CACCTTCTCCGCAGCATAGACTGC-CTGGCTGCATCGGGGGCAGCGCTCGGAGCCACCAAT-3') was synthetically engineered based on the nucleotide sequence of the hcrp gene, which encodes the 113-132 aa (35 (Fig. 1 A) . The leiomyoma extract was further purified onto CM-c as described in Methods. The eluted proteins from the CM-c also contained mitogens for both the fibroblasts and smooth musclelike cells. The CM-c eluates contained 0.02 U/,ig of activity in KW cells and 0.008 U/jzg in NIH/3T3 fibroblasts, indicating that CM-c purified by fivefold the leiomyomal mitogen(s) in KW cells. In contrast, the CM-c eluates contained less activity in NIH/3T3 fibroblasts compared with crude leiomyoma extracts (Fig. 1 B) . These data suggest that important mitogen(s) for fibroblasts possibly passed through CM-c under these experimental conditions. Indeed, compared with the eluted fractions from CM-c, the pass-through fractions contained twice as much mitogenic activity (0.017 U/ag) in fibroblasts.
The CM-c eluates were diluted and rechromatographed on HS-c as described in Methods. The fractions eluted from heparin-Sepharose contained 0.3 U/jtg mitogenic activity in KW cells and 0.2 U/fg in NIH/3T3 fibroblasts ( Fig. 1 C) , -75-fold purification in the KW cell-specific activity (Table I) .
The HS-c eluates were fractionated using cartridges of C18 silica as described in Methods. Eluted material contained 6.25 U/,4g mitogenic activity in KW smooth muscle-like cells and 0.28 U/tzg in NIH/3T3 fibroblasts (Fig. 1 D) . This step contributed to 1,562.5-fold purification of the mitogen(s) in smooth muscle-like cells and 14-fold purification in NIH/3T3 cells, suggesting purification of preferential mitogen(s) for human smooth muscle cells (8, 10, 11) .
We further purified the smooth muscle cell-specific activity using linear gradient rHPLC (Fig. 2) . Aliquots containing 75 ng/ml of the peptide(s) eluted by 35% of ACN in a linear HPLC gradient (28-44% ACN in 0.1% TFA within 40 min) equivalently stimulated KW smooth muscle-like cells with 100 ng/ml of IGF-I (Fig. 2) 3T3 cells (Fig. 2, middle and lower panels ). An additional step of rHPLC using the same linear gradient finally purified - lated tritiated thymidine incorporation and DNA content of KW cells in a dose-dependent manner (Fig. 3) . Evaluating the mitogenic activity as units per microgram, we calculated overall purification by 31,000-fold (Table I) . By SDS-PAGE, we analyzed the proteins eluted by the HS-c, cartridges of C18 silica, and the linear rHPLC gradient; the latter (LDGF) was a 17-to 18-kD protein (Fig. 4) . Sequence analysis confirmed final purification revealing a partial NH2-terminal aa sequence of the putative LDGF ( 1-20 aa) identical to 113-132 aa of the hCRP, encompassing part of the second zinc-finger "LIM motif", defined by C-X2-C-X17-H-X2-C (C -Pro-Arg-5 -Ser-Gln-Ala-Val-Tyr-Ala-AlaGlu-Lys-Val-lle-Gly-Ala-Gly-Lys-Ser-Trp-His-Lys-Ala-Cys) (35). The complete zinc-finger region is encoded by exons 4 and 5 of hCRP cDNA (Table II) .
To investigate whether the mitogenic activity of purified extracts is linked to the obtained aa sequence, we synthetically engineered three peptides encompassing (a) peptide A, part of the NH2-terminal of hCRP (1-10 aa (Table III) . The mitogenicity of the peptide B was comparable to this of purified leiomyoma extracts, thus definitely confirming that this aa sequence was a link to the putative LDGF in leiomyoma extracts.
To assess the corresponding size of the LDGF mRNA in uterine tissues, we extracted the total mRNA of leiomyoma and myometrium, which was further analyzed by Northern blots. For this analysis, we used the radiolabeled oligonucleotide probe synthetically engineered as described in Methods. This probe was engineered based on the cDNA sequence that encodes the NH2-terminal aa sequence of the LDGF. Northern analysis documented the presence of a discrete signal band of 1.9-kb LDGF mRNA (Fig. 5) , which corresponded also to the expected size of hCRP mRNA (35).
Analysis of the relative expression of the LDGF mRNA depicted by this oligonucleotide probe in uterine tissues (n = 4; leiomyoma vs adjacent myometrium of the same uterus) documented a three-to sixfold higher mRNA expression in leiomyoma (L) than in myometrium (M) by in situ hybridization (L/M: A = 6-fold; B = 6-fold; C = 4.5-fold; and D = 3-fold; Figs. 6 and 7) . 
Discussion
Although the effects of sex steroid hormones on the development, growth, and evolution of uterine leiomyomas are unquestionable, the mechanism of this action is unclear (36, 37) . Recently, the presence of growth substances in normal and neoplastic uterine tissues was documented (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) 38) , implicating growth substances as mediators of the effects of sex steroid hormones in the physiopathologic aspects of this tissue, including leiomyomas (38 and references therein). Our previous studies established that (a) myometrial and leiomyomal extracts contain mitogen(s ) of a proteinaceous nature (7); (b) cartridges of C18 silica effectively retain these mitogens (8, 9) ; and (c) mitogens are retained and can be eluted from CM-c and HS-c (10, 11). Herein we report the final purification of the LDGF for human smooth muscle-like cells using a purification scheme that used sequential liquid chromatography on CM-c, HS-c, cartridges of C18 silica, and ,uBondapak C18 rHPLC column. The mitogenic activity of LDGF throughout purification was assessed in the KW smooth 
There is now evidence that other proteins contain a similar motif (C-X2-C-X130-H-X2-C)-X2-(C-X2-C-X1018-C-X2-C) (40, 41, and references therein). It is noteworthy that a similar double zinc-finger motif was <-1.9 kb A B Figure 5 . An example of the discrete signal produced by the labeled oligonucleotide probe that detected a 1.9-kb mRNA size in leiomyoma (B) and normal myometrium (A) as grossly assessed by Northern blot using as reference the elution position of 18S mRNA. also predicted in the protein sequence of an estrogen-stimulated cDNA isolated from rat C6 glioma cells (rESPli) (42) .
The biologic importance of the double zinc-finger motif (hCRP-like) or single-finger (cysteine-rich rat and mouse intestinal protein-like) proteins is still unknown. The zinc finger is suggestive of an ability to bind DNA and RNA, possibly acting as transcriptional factors and is also suggestive of an ability to bind zinc ion and iron-sulfur clusters (35). It is interesting that hCRP is the product of an immediate response gene with an expression profile parallel to c-myc. The coordinate regulation of hcrp and c-myc suggests that these genes respond to the same regulatory pathways and may share transcription control features during the Go to S transition. Although it is not clear that the shared LIM/double-finger domain dictates a commonality of function for this family of proteins, hCRP was the first to be identified as a primary response gene and thus possesses apparent biologic significance (40).
To definitely link the obtained amino acid sequence with the putative LDGF in leiomyoma extracts and to test the possible relationship with hCRP, we synthetically engineered three peptides comprising (a) part of the NH2-terminal of hCRP; (b) the purified NH2-terminal of LDGF; and (c) part of the COOHterminal of hCRP. Analysis of mitogenic activity documented that the synthetic peptide that corresponded to the NH2-terminal sequence of purified material stimulated only the proliferation ([3H] thymidine incorporation) and cell growth (DNA content and cell number) of KW smooth muscle-like cells. Therefore, sequence analysis was on the putative LDGF in leiomyoma extracts. Because this synthetic peptide and aliquots of the purified leiomyoma extracts were mitogenic in KW cells grown in serum-free medium or culture medium containing limited calf serum (0.5%), it is conceivable that LDGF is a growth factor enabling smooth muscle cells to enter from the GO/GI phase to the S phase of the cell cycle. This is compatible with the proposed role of products of various early response genes such as c-myc and hcrp (40).
Because the oligonucleotide probe used in our study detected threefold up to sixfold higher LDGF mRNA expression in leiomyomas compared with adjacent myometrium in the proliferative phase of the menstrual cycle, we believe that LDGF is probably the major mitogen for smooth muscle cells in uterine leiomyomas. Moreover, this oligonucleotide probe hybridized with a 1.9-kb mRNA similar to the expected hCRP mRNA size, suggesting that limited proteolysis of hCRP possibly generates the LDGF in leiomyoma tissues. It is noteworthy that the posi- tion 112-113 (Lys-Ile) of hCRP corresponding to the start of the NH2-terminal sequence of purified LDGF is a potential site for trypsin-like and endopeptidase lysine C-like enzyme action. In this context, the assessment of possible overexpression of hCRP (product of an early response gene leading cells from Go to S phase of cell cycle) and intracellular processing by endopeptidases generating this LDGF is an attractive field for further investigation.
Against this hypothesis stands the fact that at least theoretically limited proteolysis in position 112-1 13 aa of hCRP should generate a hCRP fragment no bigger than 9-10 kD (hCRP is 23.4 kD; 113-193 is an 80-aa long sequence). Our data documented that the purified LDGF was 17-18 kD on SDS-PAGE. Therefore, the LDGF may contain only partial homology to hCRP. This homology possibly exists in its NH2-terminal part that contains a LIM motif identical to the second zinc-finger of hCRP. Alternatively, LDGF and hCRP could be generated by the same gene using different promoters or alternative splicing as exemplified by the steroidogenic factor 1 (SF-1), an orphan nuclear receptor and the embryonal long term repeat-binding protein (ELP) (43). ELP possesses 78 additional aa in the NH2-terminal region and 57 different aa in the COOH-terminal region, whereas SF-1 contains 131 additional aa in the COOHterminal region. There also exists 330 common aa between SF-1 and ELP. It is noteworthy that SF-i possesses a zinc-finger and stimulates the expression of steroidogenic enzymes (43) as well as is also essential for adrenal and gonadal development (43) and sexual differentiation (44). In contrast, the function and role of the ELP is still unclear (43, 44).
In conclusion, our data partially identified the LDGF for human uterine smooth muscle cells and documented a threeto sixfold higher expression of LDGF mRNA in leiomyoma compared with adjacent myometrium. We conclude that LDGF is probably the major mitogen for smooth muscle cells in uterine leiomyomas.
